Vol. XVIII · Free shipping $75+ · Read the collection
Feature · Product Review
glutathione in ovarian cancer a double-edged sword

glutathione in ovarian cancer a double-edged sword responsive nanomedicine leverages tumor redox imbalance for targeted theranostics | Discover Oncology Redox-Regulated Iron Metabolism and Ferroptosis

Redox Regulated Iron Metabolism and Ferroptosis in Ovarian Cancer: Molecular Insights and Therapeutic Opportunities Living on the Edge: ROS Homeostasis in Cancer Cells and Its Potential as a Therapeutic Target PMC Glutathione in Ovarian Cancer: A Double Edged Sword Frontiers The role of macrophage polarization in ovarian cancer: from molecular mechanism to therapeutic potentials Metabolic reprogramming of three major nutrients in platinum resistant ovarian cancer PMC

SKU: 20731405028 · From www.ohotnichi-sezoni.com

4.9
USD24.61 USD59.61

Pay in 4 interest-free payments of $6.15 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Aug 7 - Aug 12

Description

doi: 10.3390/nu11092165 535 MirandaAMStelutiJFisbergRMMarchioniDM

glutathione in ovarian cancer a double-edged sword responsive nanomedicine leverages tumor redox imbalance for targeted theranostics | Discover Oncology Redox-Regulated Iron Metabolism and Ferroptosis

While menadione (vitamin K3) is a created version of vitamin K, phylloquinone (vitamin K1) and menaquinones (vitamin K2, MK-n) are found naturally in food (57)

glutathione in ovarian cancer a double-edged sword responsive nanomedicine leverages tumor redox imbalance for targeted theranostics | Discover Oncology Redox-Regulated Iron Metabolism and Ferroptosis

10.1001/archinte.134.3.534

glutathione in ovarian cancer a double-edged sword responsive nanomedicine leverages tumor redox imbalance for targeted theranostics | Discover Oncology Redox-Regulated Iron Metabolism and Ferroptosis

G., Ohura, T., & Gaustadnes, M

glutathione in ovarian cancer a double-edged sword responsive nanomedicine leverages tumor redox imbalance for targeted theranostics | Discover Oncology Redox-Regulated Iron Metabolism and Ferroptosis

The other risk factors were patients with CHILD B/C (OR 6.8), patients who had scarred tissue at the banding site as assessed by the endoscopist OR 3.75), using more than 5 bands ( OR 2.4) and if bands were applied at the perforating zone(OR 3.5)

glutathione in ovarian cancer a double-edged sword responsive nanomedicine leverages tumor redox imbalance for targeted theranostics | Discover Oncology Redox-Regulated Iron Metabolism and Ferroptosis
Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

QK041

US$ 26.20

4.0 (11 reviews)

IGF-1LR3

US$ 23.49

5.0 (24 reviews)

IGF-1 LR3

US$ 23.48

4.3 (13 reviews)

IGF-1/LR3

US$ 22.12

4.1 (13 reviews)

recommand products